Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies

Psychological Medicine

Volumn 35, Issue 3, 2005, Pages 307-315

  Verdoux, Hélène ^a,b   Lagnaoui, Rajaa ^a   Begaud, Bernard ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DOSE RESPONSE; DRUG EXPOSURE; DRUG USE; DRUG WITHDRAWAL; EPIDEMIOLOGICAL DATA; FOLLOW UP; GERIATRIC PATIENT; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MEDLINE; MENTAL DISEASE; META ANALYSIS; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; PEER REVIEW; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

AGED; BENZODIAZEPINES; COGNITION DISORDERS; DEMENTIA; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 14944355737     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291704003897     Document Type: Review

References (25)

1. Allard, J., Artero, S. & Ritchie, K. (2003). Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. International Journal of Geriatric Psychiatry 18, 874-878.
2. Balzer, D. G., Kessler, R. C., McGonable, K. A. & Swartz, M. S. (1994). The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. American Journal of Psychiatry 151, 979-986.
3. Barker, M. J., Greenwood, K. M., Jackson, M. & Crowe, S. F. (2004). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsychology 19, 437-454.
4. Bégaud, B.(2000). Dictionary of Pharmacoepidemiology. John Wiley: Chichester.
5. Curran, H. V. (1991). Benzodiazepines, memory and mood: a review. Psychopharmacology 105, 1-8.
6. Curran, H. V., Collins, R., Fletcher, S., Kee, S. C., Woods, B. & Iliffe, S. (2003). Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychological Medicine 33, 1223-1237.
7. Dealberto, M. J., McAvay, G. J., Seeman, T. & Berkman, L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry 12, 567-574.
8. Fastbom, J., Forsell, Y. & Winblad, B. (1998). Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Disease and Associated Disorders 12, 14-17.
9. Hanlon, J. T., Horner, R. D., Schmader, K. E., Fillenbaum, G. G., Lewis, I. K., Wall Jr., W. E., Landerman, L. R., Pieper, C. F., Blazer, D. G. & Cohen, H. J. (1998). Benzodiazepine use and cognitive function among community-dwelling elderly. Clinical Pharmacology and Therapeutics 64, 684-692.
10. Jorm, A. F. (2000). Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 46, 219-227.
11. Kessler, R. C., Little, R. J. A. & Groves, R. M. (1995). Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiological Review 17, 192-204.
12. Lagnaoui, R., Begaud, B., Moore, N., Chaslerie, A., Fourrier, A., Letenneur, L., Dartigues, J. F. & Moride, Y. (2002). Benzodiazepine use and risk of dementia: a nested case-control study. Journal of Clinical Epidemiology 55, 314-318.
13. Letenneur, L., Larrieu, S. & Barberger-Gateau, P. (2004). Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies. Biomedicine and Pharmacotherapy 58, 95-99.
14. Maubach, K. (2003). GABA(A) receptor subtype selective cognition enhancers. Current Drug Target in CNS and Neurological Disorders 2, 233-239.
15. Moride, Y. & Abenhaim, L. (1994). Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiological research. Journal of Clinical Epidemiology 47, 731-737.
16. Mukamal, K. J., Kuller, L. H., Fitzpatrick, A. L., Longstreth Jr., W. T., Mittleman, M. A. & Siscovick, D. S. (2003). Prospective study of alcohol consumption and risk of dementia in older adults. Journal of the American Medical Association 289, 1405-1413.
17. Oslin, D. W. & Cary, M. S. (2003). Alcohol-related dementia: validation of diagnostic criteria. American Journal of Geriatric Psychiatry 11, 441-447.
18. Paterniti, S., Dufouil, C. & Alperovitch, A. (2002). Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. Journal of Clinical Psychopharmacology 22, 285-293.
19. Regier, D., Farmer, M., Rae, D., Locke, B., Keith, S., Judd, L. & Goodwin, F. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association 264, 2511-2518.
20. Rose, G. (1992). The Strategy of Preventive Medicine Oxford University Press: Oxford.
21. Ruitenberg, A., van Swieten, J. C., Witteman, J. C., Mehta, K. M., van Duijn, C. M., Hofman, A. & Breteler, M. M. (2002). Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359, 281-286.
22. Schweizer, E. & Rickels, K. (1998). Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatrica Scandinavica Supplement 393, 95-101.
23. Verdoux, H. & Begaud, B. (2004). What do (don't) we know about utilization and impact of psychotropic medications in real-life conditions? British Journal of Psychiatry 185, 93-94.
24. Waddington, J. L. & Youssef, H. A. (1996). Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 26, 681-688.
25. Waddington, J. L., Youssef, H. A. & Kinsella, A. (1990). Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 20, 835-842.